Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 3
1987 1
1988 2
1989 1
1990 4
1991 4
1992 8
1993 3
1994 1
1995 10
1996 4
1997 6
1998 4
1999 3
2000 1
2002 1
2004 2
2005 1
2007 1
2010 5
2012 1
2013 1
2015 1
2016 1
2017 1
2018 2
2019 3
2020 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen.
Poole A, Karuppiah V, Hartt A, Haidar JN, Moureau S, Dobrzycki T, Hayes C, Rowley C, Dias J, Harper S, Barnbrook K, Hock M, Coles C, Yang W, Aleksic M, Lin AB, Robinson R, Dukes JD, Liddy N, Van der Kamp M, Plowman GD, Vuidepot A, Cole DK, Whale AD, Chillakuri C. Poole A, et al. Among authors: plowman gd. Nat Commun. 2022 Sep 10;13(1):5333. doi: 10.1038/s41467-022-32811-1. Nat Commun. 2022. PMID: 36088370 Free PMC article.
Evolution of protein kinase signaling from yeast to man.
Manning G, Plowman GD, Hunter T, Sudarsanam S. Manning G, et al. Among authors: plowman gd. Trends Biochem Sci. 2002 Oct;27(10):514-20. doi: 10.1016/s0968-0004(02)02179-5. Trends Biochem Sci. 2002. PMID: 12368087 Review.
The discovery and validation of new drug targets in cancer.
Courtneidge SA, Plowman GD. Courtneidge SA, et al. Among authors: plowman gd. Curr Opin Biotechnol. 1998 Dec;9(6):632-6. doi: 10.1016/s0958-1669(98)80142-0. Curr Opin Biotechnol. 1998. PMID: 9889138 Review.
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity.
Kotanides H, Li Y, Malabunga M, Carpenito C, Eastman SW, Shen Y, Wang G, Inigo I, Surguladze D, Pennello AL, Persaud K, Hindi S, Topper M, Chen X, Zhang Y, Bulaon DK, Bailey T, Lao Y, Han B, Torgerson S, Chin D, Sonyi A, Haidar JN, Novosiadly RD, Moxham CM, Plowman GD, Ludwig DL, Kalos M. Kotanides H, et al. Among authors: plowman gd. Cancer Immunol Res. 2020 Oct;8(10):1300-1310. doi: 10.1158/2326-6066.CIR-20-0304. Epub 2020 Jul 27. Cancer Immunol Res. 2020. PMID: 32873605
78 results